Diabetic ketoacidosis

被引:239
作者
Dhatariya, Ketan K. [1 ,2 ]
Glaser, Nicole S. [3 ]
Codner, Ethel [4 ]
Umpierrez, Guillermo E. [5 ]
机构
[1] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Elsie Bertram Diabet Ctr, Colney Lane, Norwich, Norfolk, England
[2] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England
[3] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA
[4] Univ Chile, Inst Maternal & Child Res, Sch Med, Santiago, Chile
[5] Emory Univ, Sch Med, Diabet & Endocrinol, Atlanta, GA 30322 USA
来源
NATURE REVIEWS DISEASE PRIMERS | 2020年 / 6卷 / 01期
基金
美国国家卫生研究院;
关键词
HYPEROSMOLAR HYPERGLYCEMIC STATE; SUBCUTANEOUS INSULIN INFUSION; INTRAVENOUS REGULAR INSULIN; MULTIPLE ORGAN FAILURE; AMINO-ACID LEVELS; LOW-DOSE INSULIN; QUALITY-OF-LIFE; CEREBRAL EDEMA; SEVERE HYPOGLYCEMIA; OXIDATIVE STRESS;
D O I
10.1038/s41572-020-0165-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic ketoacidosis (DKA) is the most common acute hyperglycaemic emergency in people with diabetes mellitus. A diagnosis of DKA is confirmed when all of the three criteria are present - 'D', either elevated blood glucose levels or a family history of diabetes mellitus; 'K', the presence of high urinary or blood ketoacids; and 'A', a high anion gap metabolic acidosis. Early diagnosis and management are paramount to improve patient outcomes. The mainstays of treatment include restoration of circulating volume, insulin therapy, electrolyte replacement and treatment of any underlying precipitating event. Without optimal treatment, DKA remains a condition with appreciable, although largely preventable, morbidity and mortality. In this Primer, we discuss the epidemiology, pathogenesis, risk factors and diagnosis of DKA and provide practical recommendations for the management of DKA in adults and children.
引用
收藏
页数:20
相关论文
共 277 条
[1]  
Abdulaziz Salman, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-2012-007312
[2]   PLASMA ACID-BASE PATTERNS IN DIABETIC-KETOACIDOSIS [J].
ADROGUE, HJ ;
WILSON, H ;
BOYD, AE ;
SUKI, WN ;
EKNOYAN, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (26) :1603-1610
[3]   Prognostic Factors in Patients Hospitalized with Diabetic Ketoacidosis [J].
Agarwal, Avinash ;
Yadav, Ambuj ;
Gutch, Manish ;
Consul, Shuchi ;
Kumar, Sukriti ;
Prakash, Ved ;
Gupta, Anil Kumar ;
Bhattacharjee, Annesh .
ENDOCRINOLOGY AND METABOLISM, 2016, 31 (03) :424-432
[4]   Immune checkpoint inhibitor-induced Type 1 diabetes: a systematic review and meta-analysis [J].
Akturk, H. K. ;
Kahramangil, D. ;
Sarwal, A. ;
Hoffecker, L. ;
Murad, M. H. ;
Michels, A. W. .
DIABETIC MEDICINE, 2019, 36 (09) :1075-1081
[5]   Adverse Events Associated with Immune Checkpoint Blockade [J].
Tervaert, Jan-Willem Cohen ;
Ye, Carrie ;
Yacyshyn, Elaine .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (12) :1164-1165
[6]   Insulin infused at 0.05 versus 0.1 units/kg/hr in children admitted to intensive care with diabetic ketoacidosis [J].
Al Hanshi, Said ;
Shann, Frank .
PEDIATRIC CRITICAL CARE MEDICINE, 2011, 12 (02) :137-140
[7]   Brugada phenocopy associated with diabetic ketoacidosis in two pediatric patients [J].
Alanzalon, Ryan E. ;
Burris, Jonathan R. ;
Vinocur, Jeffrey M. .
JOURNAL OF ELECTROCARDIOLOGY, 2018, 51 (02) :323-326
[8]   Thrombocytopenia-associated multi-organ failure caused by diabetic ketoacidosis [J].
Alsaied, Tarek ;
Goldstein, Stuart L. ;
Kaddourah, Ahmad ;
Poynter, Sue E. .
PEDIATRICS INTERNATIONAL, 2016, 58 (03) :232-234
[9]  
American College of Surgeons Committee on Trauma, 1993, ADV LIF SUPP COURS P
[10]   Side effects of atypical antipsychotic drugs [J].
Ananth, J ;
Parameswaran, S ;
Gunatilake, S .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (18) :2219-2229